Trial Profile
Clinical trial to evaluate the efficacy, safety and economic impact of reducing doses of darunavir in patients infected with HIV treated with darunavir/ritonavir once a day.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 24 May 2012 New trial record